EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enhancing the Therapeutic Profile of Dapagliflozin: Chitosan Nanoparticle Encapsulation for Intestinal Applications

Agni Klonari, Antrea-Maria Athinodorou, Eirini Papanikolaou, Anastasia Skonta, Myrto G Bellou, Lampros Lakkas, Konstantinos I Tsamis, Georgios S Markopoulos, Haralambos Stamatis, Petros Bozidis, Dimitrios Peschos, Yannis V Simos iD

FASEB BioAdvances · 2026-05 · 8 (5)

DOI: 10.1096/fba.2026-00050 ↗

Kurz gefasst

Fachartikel in der Zeitschrift FASEB BioAdvances, online erschienen am 14.05.2026. Verfasst von Agni Klonari und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Faculty of Medicine, School of Health Sciences University of Ioannina Ioannina Greece. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dapagliflozin is a sodium‐glucose cotransporter‐2 (SGLT‐2) inhibitor primarily used to treat type 2 diabetes by lowering blood glucose levels. In addition to its antidiabetic action, it has demonstrated cardioprotective and renoprotective effects, along with antioxidant, anti‐inflammatory, and anticancer activities. Encapsulation of dapagliflozin in nanocarriers represents an innovative strategy to improve existing therapies and develop targeted treatments. Such formulations can enhance solubility and stability, improve epithelial permeability and bioavailability, and reduce potential side effects. This study investigates the cellular and molecular effects of dapagliflozin encapsulated in chitosan nanoparticles, focusing on colon (Caco‐2) cells. The findings showed that free dapagliflozin significantly reduced cell viability, whereas the encapsulated form preserved high cell viability. In addition, the encapsulated drug effectively reduced reactive oxygen species levels, maintaining its antioxidant activity. Free dapagliflozin did not increase the expression of Nrf2, NFκB, or HO‐1 signaling pathways. In contrast, encapsulation in chitosan nanoparticles resulted in increased expression of all three pathways, indicating potential regulatory involvement in these signaling mechanisms.

Schlagwörter

Stichwörter der Autor:innen

SGLT2ichitosan nanoparticlesdapagliflozininflammationreactive oxygen speciessignaling pathways

Autor:innen und Institutionen

  • Department of Physiology, Faculty of Medicine, School of Health Sciences University of Ioannina Ioannina Greece.
  • Nanomedicine and Nanobiotechnology Research Group University of Ioannina Ioannina Greece.
  • Laboratory of Biotechnology, Department of Biological Applications and Technologies University of Ioannina Ioannina Greece.
  • Microbiology Department, School of Health Science, Faculty of Medicine University of Ioannina Ioannina Greece.

ORCID-Profile: Yannis V Simos

Zitieren

APA

Klonari, A., Athinodorou, A. M., Papanikolaou, E., Skonta, A., Bellou, M. G., Lakkas, L., Tsamis, K. I., Markopoulos, G. S., Stamatis, H., Bozidis, P., Peschos, D., & Simos, Y. V. (2026). Enhancing the Therapeutic Profile of Dapagliflozin: Chitosan Nanoparticle Encapsulation for Intestinal Applications. FASEB BioAdvances, 8(5). https://doi.org/10.1096/fba.2026-00050

Vancouver

Klonari A, Athinodorou AM, Papanikolaou E, Skonta A, Bellou MG, Lakkas L, et al. Enhancing the Therapeutic Profile of Dapagliflozin: Chitosan Nanoparticle Encapsulation for Intestinal Applications. FASEB BioAdvances. 2026;8(5). doi:10.1096/fba.2026-00050

BibTeX
@article{Klonari2026,
  author = {Klonari, Agni and Athinodorou, Antrea-Maria and Papanikolaou, Eirini and Skonta, Anastasia and Bellou, Myrto G and Lakkas, Lampros and Tsamis, Konstantinos I and Markopoulos, Georgios S and Stamatis, Haralambos and Bozidis, Petros and Peschos, Dimitrios and Simos, Yannis V},
  title = {Enhancing the Therapeutic Profile of Dapagliflozin: Chitosan Nanoparticle Encapsulation for Intestinal Applications},
  journal = {FASEB BioAdvances},
  year = {2026},
  volume = {8},
  number = {5},
  doi = {10.1096/fba.2026-00050}
}
Kostenlos starten →